HANSOH PHARMAC. HD-00001 (3KY) — Financial Flexibility Index
HANSOH PHARMAC. HD-00001 (3KY) has a Financial Flexibility Index of 1.59x as of December 2025. Free cash flow of €7.23 Billion (operating CF €6.74 Billion minus capex €489.46 Million) represents 2% of total liabilities (€4.54 Billion). Explore capital reinvestment ratio of HANSOH PHARMAC. HD-00001 to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
HANSOH PHARMAC. HD-00001 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for HANSOH PHARMAC. HD-00001 across 5 annual periods. Check 3KY total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Financial Flexibility Index for HANSOH PHARMAC. HD-00001 (2021–2025)
Year-by-year free cash flow to debt coverage for HANSOH PHARMAC. HD-00001. For the full cash flow conversion analysis, see cash flow conversion of HANSOH PHARMAC. HD-00001.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.59x | €7.23 Billion | €6.74 Billion | €4.54 Billion | ▲ +8.2% |
| 2024 | 1.47x | €4.39 Billion | €3.86 Billion | €2.98 Billion | ▲ +206.8% |
| 2023 | 0.48x | €3.48 Billion | €3.12 Billion | €7.24 Billion | ▲ +16.5% |
| 2022 | 0.41x | €3.03 Billion | €2.74 Billion | €7.35 Billion | ▼ -3.7% |
| 2021 | 0.43x | €3.05 Billion | €2.58 Billion | €7.13 Billion | — |